Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Sirtex Medical
AddedFeb 15, 2024
UpdatedJun 28, 2026
Sirtex Medical

Sirtex Medical

Public

Sirtex Medical Inc. offers global, innovative oncology solutions, specializing in liver cancer treatment.

HQ
Woburn, MA, US
Founded
2001
Overview
Compare
Employees
Website

Sirtex Medical Inc. specializes in innovative oncology solutions, focusing on the treatment of liver cancer. The company’s core product, SIR-Spheres Y-90 resin microspheres, provides a radioactive treatment option for patients with inoperable liver cancer. Sirtex Medical serves a global market, offering advanced medical technologies to improve patient outcomes and enhance the quality of life for those affected by liver cancer.

Sirtex Medical has made significant strides in the field of oncology, with its SIR-Spheres Y-90 resin microspheres being widely recognized and utilized in the medical community. The company’s impact is evident through its extensive global reach and the adoption of its treatment solutions by healthcare providers worldwide. Sirtex Medical continues to innovate and lead in the development of effective cancer treatments, contributing to advancements in medical care and patient health.

Sirtex Medical - Similar Companies

Accuray logo

Accuray

accuray.com

ViewRay logo

ViewRay

Novocure logo

Novocure

novocure.com

Clovis Oncology logo

Clovis Oncology

SRS Holdings logo

SRS Holdings

SkinCure Oncology logo

SkinCure Oncology

NED Medical logo

NED Medical

nedmedical.com

Radionetics Oncology logo

Radionetics Oncology

radionetics.com

RefleXion Medical logo

RefleXion Medical

Delcath Systems logo

Delcath Systems

delcath.com

OncoSpherix logo

OncoSpherix

oncospherix.com

Oncologix Tech logo

Oncologix Tech

Sabik Medical logo

Sabik Medical

Soteira logo

Soteira

Civatech Oncology logo

Civatech Oncology

Sirtex Medical - Quick Facts

Who are Sirtex Medical's competitors?

Companies similar to Sirtex Medical include Accuray, ViewRay, Novocure and Clovis Oncology.

When was Sirtex Medical founded?

Sirtex Medical was founded in 2001.

Where is Sirtex Medical's headquarters located?

Sirtex Medical's headquarters is located in Woburn, MA, US.

How many employees does Sirtex Medical have?

Sirtex Medical has 393 employees as of Feb 4, 2024.

Sirtex Medical - Classification

Industry
  • Medical Devices
Ownership
  • Public
Technology
  • Radiotherapy
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cancer Treatment
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies